Long-term outcomes of MICOF keratoprosthesis in the end stage of autoimmune dry eyes: An experience in China

British Journal of Ophthalmology

Volumn 96, Issue 1, 2012, Pages 28-33

  Huang, Yifei ^a   Dong, Ying ^a   Wang, Liqiang ^a   Du, Gaiping ^a   Yu, Jifeng ^a   Song, Jing ^a   Chiang, Homer H ^b  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORNEAL LEAKAGE; CORNEAL MELTING; CYLINDER LOOSENING; DRY EYE; END STAGE AUTOIMMUNE DRY EYE; EYE EXAMINATION; GLAUCOMA; HUMAN; KERATOPROSTHESIS; MEDICAL RECORD REVIEW; MUCOUS MEMBRANE PEMPHIGOID; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RETROPROSTHETIC MEMBRANE FORMATION; SJOEGREN SYNDROME; STEVENS JOHNSON SYNDROME; TISSUE OVERGROWTH; VISUAL IMPAIRMENT; VITRITIS;

ADULT; AGED; AGED, 80 AND OVER; AUTOIMMUNE DISEASES; CHINA; CORNEAL STROMA; DRY EYE SYNDROMES; EAR CARTILAGE; FOLLOW-UP STUDIES; GLAUCOMA; HUMANS; MIDDLE AGED; PEMPHIGOID, BENIGN MUCOUS MEMBRANE; PROSTHESES AND IMPLANTS; PROSTHESIS FAILURE; REOPERATION; RETROSPECTIVE STUDIES; SJOGREN'S SYNDROME; STEVENS-JOHNSON SYNDROME; SURGICAL WOUND INFECTION; TIME; VISUAL ACUITY;

EID: 84455163307     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjo.2010.193029     Document Type: Article

References (16)

1. Solomon A, Ellies P, Anderson DF, et al. Long-term outcome of keratolimbal allograft with or without penetrating keratoplasty for total limbal stem cell deficiency. Ophthalmology 2002;109:1159-66. (Pubitemid 34546927)
2. Ilhan-Sarac O, Akpek EK. Current concepts and techniques in keratoprosthesis. Curr Opin Ophthalmol 2005;16:246-50. (Pubitemid 41073308)
3. Sayegh RR, Ang LP, Foster CS, et al. The Boston keratoprosthesis in Stevens-Johnson syndrome. Am J Ophthalmol 2008;145:438-44.
4. Liu C, Okera S, Tandon R, et al. Visual rehabilitation in end-stage inflammatory ocular surface disease with the osteo-odonto-keratoprosthesis: results from the UK. Br J Ophthalmol 2008;92:1211-17.
5. Hicks CR, Crawford GJ, Dart JK, et al. AlphaCor: clinical outcomes. Cornea 2006;25:1034-42. (Pubitemid 44885265)
6. Huang YF, Wang LQ, Wang FX. Clinical application of keratoprosthesis for corneal opacity unsuitable for keratoplasty. Zhonghua Yan Ke Za Zhi 2003;39:578-81.
7. Chang YS, Huang FC, Tseng SH, et al. Erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis: acute ocular manifestations, causes, and management. Cornea 2007;26:123-9.
8. Berra A, Dutt JE, Nouri M, et al. Heat shock protein expression in human conjunctiva. Invest Ophthalmol Vis Sci 1994;35:352-7. (Pubitemid 24078086)
9. Huang YF, Yu JF, Liu L, et al. Moscow eye microsurgery complex in Russia keratoprosthesis in Beijing. Ophthalmology 2011;118:41-6.
10. Yaghouti F, Nouri M, Abad JC, et al. Keratoprosthesis: preoperative prognostic categories. Cornea 2001;20:19-23. (Pubitemid 32038149)
11. Saito T, Nishida K, Sugiyama H, et al. Abnormal keratocytes and stromal inflammation in chronic phase of severe ocular surface diseases with stem cell deficiency. Br J Ophthalmol 2008;92:404-10. (Pubitemid 351363540)
12. Xu JT, Chen JS. Mitigation of keratoprosthesis prolapse with recipient strengthening. Rec Adv Ophthalmol 2009;29:2-4.
13. Hicks CR, Crawford GJ. Melting after keratoprosthesis implantation: the effects of medroxyprogesterone. Cornea 2003;22:497-500. (Pubitemid 36909724)
14. Netland PA, Terada H, Dohlman CH. Glaucoma associated with keratoprosthesis. Ophthalmology 1998;105:751-7. (Pubitemid 28180230)
15. Nouri M, Durand ML, Dohlman CH. Sudden reversible vitritis after keratoprosthesis: an immune phenomenon? Cornea 2005;24:915-19. (Pubitemid 41688521)
16. Ma X, Li ZH, Huang YF, et al. Hydroxyapatite modified titanium promotes superior adhension and proliferation of corneal fibroblast in comparison with pure titanium. Int J Ophthalmol 2007;7:317-20.